Dowling-Degos Disease and Hidradenitis suppurativa. Epidemiological and Clinical Study of 15 patients and Review of the Literature.
Dowling-Degos Disease and Hidradenitis suppurativa. Epidemiological and Clinical Study of 15 patients and Review of the Literature. Acta Derm Venereol. 2019 May 23;: Authors: Agut-Busquet E, González-Villanueva I, Romani de Gabriel J, Pascual JC, Ribera Pibernat M, Luelmo J PMID: 31120546 [PubMed - as supplied by publisher]
Conditions: Hidradenitis Suppurativa; Acne Inversa; Suppurative Hidradenitis Interventions: Drug: bermekimab; Drug: placebo Sponsor: XBiotech, Inc. Not yet recruiting
CONCLUSIONS: Considering the lack of strong evidence regarding wound care in HS, the authors propose the new concept of HS-TIME, based on the TIME wound bed preparation rules, as a new, helpful, easy-to-use tool that may assist physicians in identifying the best wound approach in these patients. PMID: 31298658 [PubMed - as supplied by publisher]
Purpose of review Several chronic inflammatory skin disorders have been linked to metabolic syndrome (MetS) and an increased risk for cardiovascular disease. In this review, we will summarize the recent evidence on the association between psoriasis, hidradenitis suppurativa (HS), and atopic dermatitis (AD) and metabolic syndrome with careful attention to this association among the pediatric population. Recent findings Historically, psoriasis has exhibited the most robust association with MetS in the literature. Recent studies show that the prevalence of MetS appears to be higher among patients with HS and can be assoc...
This systematic review and meta-analysis investigates the associated risk of inflammatory bowel disease in patients with hidradenitis suppurativa.
There is a dearth of high-level evidence guiding our understanding of the epidemiology, pathophysiology, and treatment of hidradenitis suppurativa (HS). Despite an estimated prevalence of 1% in Western populations and quality of life impairment often exceeding other chronic skin diseases, annual HS-related publications lag far behind annual publications for other common and rare skin diseases (Figure, A). Federal funding to study HS wanes in comparison to funding for other chronic cutaneous dermatoses, with only 0.1% of the National Institute of Arthritis and Musculoskeletal and Skin Diseases total research funds for skin ...
This article is protected by copyright. All rights reserved. PMID: 31286486 [PubMed - as supplied by publisher]
PMID: 31281960 [PubMed - as supplied by publisher]
Conclusion: CPT may be useful as a first-line treatment of sacral HS. PMID: 31259621 [PubMed - as supplied by publisher]